病例报告:常见的可变免疫缺陷表型和粒状淋巴细胞间歇性肺病与新型SOCS1变异
María Soledad Caldirola1,2, Espantoso Daiana1, Andrea Cecilia Gomez Raccio1
1Servicio de Inmunología, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina.
常见变性免疫缺陷 (CVID) 患者可能会患上严重的肺部疾病. 这项研究详细介绍了阿根廷首位患有CVID和与SOCS1基因变异相关的粒状淋巴细胞间歇性肺病的患者.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
背景情况:
- 常见变性免疫缺陷 (CVID) 是一种主要免疫缺陷,其特点是抗体产生受损,感染易感性增加.
- 冠状病毒感染的并发症包括自身免疫,淋巴扩散,肠病和恶性瘤,慢性肺病是死亡的主要原因.
- 粒状淋巴细胞间歇性肺病 (GLILD) 是CVID患者显著的肺表现.
研究的目的:
- 报告阿根廷第一个患有粒状淋巴细胞间歇性肺病的常见可变免疫缺陷患者的病例.
- 研究该患者疾病的遗传基础,重点关注参与免疫细胞发育和功能的基因.
主要方法:
- 临床病例介绍和详细的病史.
- 基因分析用于识别相关免疫系统基因的变异.
- 对CVID,GLILD和SOCS1基因功能的现有文献的综述.
主要成果:
- 该患者呈现了常见变性免疫缺陷和粒状淋巴细胞间歇性肺病的临床特征.
- 基因分析揭示了SOCS1基因中的两个异质合体变体,位于cis.
- 这代表了阿根廷患者中首个与SOCS1变异相关的GLILD相关的CVID病例.
结论:
- SOCS1基因变异可能在常见变性免疫缺陷和粒状淋巴细胞间歇性肺病的发病过程中发挥作用.
- 这一案例扩大了与CVID及其严重肺部表现相关的已知遗传景观.
- 需要进一步的研究来阐明SOCS1变异对CVID和GLILD的贡献的确切机制.
更多相关视频
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Pleiotropy
Single Nucleotide Polymorphisms-SNPs
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
